Historical deployment - Diagnostics

Digital test reading at national scale.

UnifAI's Digital Reader was selected through competitive tender for deployment in the UKHSA COVID-19 testing programme, combining smartphone-based interpretation with automated recording and digital reporting.

UK Health Security Agency logo
Digital Reader deployment in the national COVID-19 testing programme
Status
Historical national deployment
Application
COVID-19 lateral flow test interpretation
Delivery record
More than four million tests read
Connected test reading

From smartphone image to recorded result

Users photographed completed lateral flow tests through a web-based smartphone workflow. Cloud-based AI interpreted the image and returned a digitally recorded result.

The connected workflow supported automated reporting, quality assurance, review and programme-level analysis rather than leaving each result as an isolated manual reading.

Digital Reader used a standard smartphone capture workflow.

Independent evaluation in real-world use

25.49%
more true positive cases detected

In its July 2022 evaluation, UKHSA reported that the Digital Reader detected 25.49% more true positive cases than self-read lateral flow tests in its comparison with matched PCR results.

£3.64m
modelled net benefit per 1.5 million tests

UKHSA's value-for-money analysis estimated a net benefit of at least £3.64 million for adult social care, after the costs of testing and the reader. The scenario assumed 5% prevalence and 70% of the population vaccinated and boosted.

“We recommend it should be immediately implemented in all settings that use lateral flow devices.”
UKHSA, July 2022 evaluation of real-world COVID-19 digital test reading, page 44.

What the deployment demonstrates

The programme provides evidence of objective smartphone-based test interpretation, connected reporting and delivery at national scale.

Test coverage and regulatory history

Digital Reader was trained and verified for five types of COVID-19 lateral flow test. It received MHRA exceptional-use authorisation for home use during the national testing programme.

Image detail

Privacy preferences

This website uses necessary technology to deliver pages and handle enquiries. Optional analytics, advertising and video embeds are switched off.

Wix hosting and security — necessary
Wix delivers the website and protects requests. The sec-fetch-unsupported security cookie lasts for the browser session.
Wix enquiry session — necessary
The wixSession cookie supports the visitor session used by the enquiry form. It lasts for the browser session.
Analytics, advertising and embedded video — optional
Off. No optional tracking tags, advertising cookies or video players are loaded by this website. External links open the provider’s own service.

See the Cookie Notice and Privacy Notice.